Articles
~ Exploring AI, blockchain and packaging ~ From personalised medicine and cannabis oil, to track and trace and the Falsified Medicines Directive (FMD), the pharmaceutical industry has witnessed a whole host of changes over the past decade. But what does the future hold? Here, Adrian Pittock, marketing director at pharmaceutical consumables supplier Valley Northern, looks at pharmaceutical trends for 2020. Artificial intelligence Ar…
The growing appetite and opportunity for increased personalisation of medical treatment plans, devices and medicines is clear, promising to improve the efficacy and safety of life sciences products and services for patients. Yet this in turn places a growing burden on manufacturers and supply chains to manage multiplying stock-keeping units, as the number of variants of each product increases. Batches are becoming smaller and the number of packaging and labelling variants are soaring to meet the growing demand of personalisation. Managing this logistical complexity reliably, efficiently and consistently across markets and for all target…
The COVID-19 pandemic has created an unprecedented challenge for pharmaceutical companies thrusting them into an unforeseen scenario where they must manage competing priorities for the protection of both their patients and their personnel. As companies strive to manage and maintain their supply chains to minimise patient impact, they are required to restrict travel, follow government directives limiting social contact and ensure they prevent exposure of their personnel to infection with COVID-19. In the pharmaceutical industry there is an emphasis on robu…
A new study gives weight to emerging evidence that a loss of smell and taste is a common symptom of COVID-19 – according to University of East Anglia (UEA) smell expert Prof Carl Philpott. The study, from Kinds College London, looked at responses from more than 400,000 people reporting suspected COVID-19 symptoms via an app. It found that 59 per cent of 579 people who said they had tested positive for the virus reported a loss of smell or taste. But loss of smell and taste are also signs of other infections, such as the common cold. Prof Philpott, from UEA’s Norwich Medical School, said: "Coronaviruses have been associated with what we refer to as post-vi…
As readers of this article who have most likely worked in the regulatory, research, development or manufacturing area for drug products, I’m sure you have been drawn to read the many scientific and technical advances that are being fast tracked at present in response to the current global emergency. For those of us in an industry who comprehend the lengthy and expensive process of drug discovery, testing and trials, the speed and urgency at which our industry is moving to develop an effective v…
The pandemic that the world is now facing is causing a lot of confusion and fear among many, especially those of us who have a compromised immune system. I am very grateful to have lived 12 years since my diagnosis of pancreatic cancer and, as every year passes, that awful and frightening diagnosis feels ever more distant and as time goes on it is thought that when I eventually die, that it will be of something else. Will it be coronavirus? Well, I just don’t know. When it started It was the beginning of March that we had a team meeting at Pancreatic Cancer Action about the coronavirus and how we can protect our staff. As I had had my spl…
An introduction to NICE Set up in the UK in 1999 to create consistency across NHS treatment and care, the National Institute for Health and Clinical Excellence (or NICE) now has an international reputation for its guidance (including guidelines) on the management and treatment of illnesses. Currently, NICE guidelines are prepared by specifically formed groups, which consider the product or treatment in question, taking into account the views of any interested parties and looking at cost as well as the medical efficacy of the…
As we’re all aware by now, the coronavirus outbreak Is having a significant impact on our daily lives - and it seems it will for some time to come.At PharmiWeb, we’re taking the government’s recommendations very seriously, and are implementing changes where required and providing clear guidelines to our team.Whilst remaining committed to providing you with the best possible service.As a mainly on-line company, our team is already set up to work flexibly from home (many of us already do), and our servers along with the majority of our support services (such as our email and phone systems) are cloud-based. This means it will be bus…
The first outbreak of COVID-19 was detected in Wuhan, Hubei province, China, with an epidemiological link to the Huanan Seafood Wholesale Market, where sale of live animals is conducted. After China's National Health Commission submitted reports, regarding the health condition of people and onset of the novel viral infection, to the World Health Or…
London, UK - A therapy app is encouraging users to reduce the risk of depression, which affects 300 million people worldwide, by changing their eating habits to a diet high in fruits, vegetables, fish, olive oil, nuts and seeds - and low in sugar and saturated fat. Based on the latest clinical psychology and nutrition research, the Flow app helps users to…
We are looking for Speakers and Delegates who are interested to participate at our upcoming 29th Edition of World Congress on Nursing Education & Research during May 25-26, 2020 Dublin, Ireland. Nursing Education-2020 aims to discover advances in health practice, management and education with the leading world doctors, registered nurses, health care professionals, professors, research fellows, universities, students, dir…
London, United Kingdom – February 26, 2020 – AXON Communications is pleased to announce today that it has been recognised for Excellence in Wellbeing by Great Place to Work® for the second consecutive year. The Excellence in Wellbeing recognition is based on employee responses to questions related to six dimensions that drive a culture of employ…
From global economic concerns and escalating trade tensions to the ‘closed border mentality’ being adopted by some nation states, as we enter the new decade, there’s a real sense that the era of fervent globalisation and the pursuit of ever-more frictionless trade may now be at an end. Whatever happens next, however, it’s clear that digitisation has forever changed the face of business. Industries have been overhauled, disrupted and in some cases entirely dismantled by scores of agile, digitally-driven compa…
This year, around 200,000 people in the UK – roughly one every three minutes – will be diagnosed with Type 2 diabetes (T2D). For many, it will be a daunting prospect; the condition can lead to long-term complications such as sight loss, amputation or kidney failure, as well as increasing the risk of heart attack or stroke. However, while the potential implications of diabetes are well documented, the disease is commonly misunderstood. A high percentage of people think that T2D is untreatable and irreversible. Thankfully they’re mistaken. Managed properly…
Do medical device manufacturers bring new advantages to labelling compliance thanks to their engineering-orientated approach? asks Kallik’s David Bennett In the pharmaceutical world, labelling change management is a complex enough affair already. But it’s made all the more challenging because the physical labelling side tends to be handled by regulatory and manufacturing teams, while the artwork by design teams is typically managed at third-party agencies. None of this is well coordinated and it can be difficult to see the current status of output, the likely impact of planned changes, and what will be involved to roll out these changes wh…
Fake pharmaceuticals are on the rise and are readily available online, with Search Engines pivotal in directing users to infringing locations. To uncover the scale of the issue, Incopro undertook new research into the role Search Engines play in serving counterfeit and other illegal content to unwitting consumers.Search Engines are enabling illegal online pharmacies to flourish, and this puts consumers at great risk. Search engines should provide a scalable solution to help brands…
By Sharon Rindsland, Senior Manual Handling Co-ordinator, East Kent Hospitals Since 1975 worldwide obesity has nearly tripled. In 2016, more than 1.9 billion adults were classed as being overweight, of these 650 million were obese. However, this doesn’t just apply to adults, over 340 million children and adolescents aged 5-19 were overweight or obese in 2016 . Unfortunately, complications related to obesity continue post-mortem. Nursing staff and mortuary technicians often face these complications when processing and transferring overweight patients. Issues such as loss of dignity for the patient, difficulty transferring patients resulting in musculoskeletal injuries (MSI) for staff, inc…
The PM Society welcomes Caroline Benson of Cuttsy+Cuttsy and Colin Williams of GSK to the role of Chairs, succeeding Craig Bradley of Takeda who has been running the Society for three years. For the first time, industry and agencies will be equally represented as the pair join forces to lead the PM Society into the new decade. The Chairs will oversee the Executive Committee as it rolls out training and development programmes, educational meetings and interest group activities, two annual awards events and a programme encouraging collaboration across individuals and companies with the purpose of giving s…
Both Edwards Lifesciences and Teva won four Golds and one Silver each, making them joint top of the pharma charts. Roche won two Golds and two Silvers and Reckitt Benckiser (RB) two Golds. Other Gold winners on the client side included ALK, Heart UK, Immunocore, Janssen, Mundipharma, Novo Nordisk and Santen. The event is the largest in the industry awards calendar and attrac…
As life sciences firms continue invest in collating comprehensive regulated product data for compliance purposes, could they be doing more to capitalise on the insights locked within these rich digital resources. AMPLEXOR’s David Gwyn considers the untapped potential. Having digitalised and centralised all of its regulated product data, a major global pharmaceutical company recently realised that it now has unprecedented insight into the relative regulatory and market status of all of it…